Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions

Transfusion

Volumn 40, Issue 8, 2000, Pages 936-942

  Rozman, P ^a   Dovc, T ^a   Gassner, C ^a  

^a BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN;

ARTICLE; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; BLOOD SAMPLING; CELL POPULATION; ERYTHROCYTE; GENOTYPE; HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RECIPIENT; RELIABILITY;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUP ANTIGENS; BLOOD TRANSFUSION; DUFFY BLOOD-GROUP SYSTEM; FEMALE; GENOTYPE; HUMANS; KELL BLOOD-GROUP SYSTEM; KIDD BLOOD-GROUP SYSTEM; MALE; PHENOTYPE; RH-HR BLOOD-GROUP SYSTEM; TIME FACTORS;

EID: 0033840121     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2000.40080936.x     Document Type: Article

References (33)

1. Serological findings and efficiency of DNA profiling in transfused patients and their significance for identity and paternity tests
2. Molecular genetic basis of the histo-blood group ABO system
3. A rapid and simple ABO genotype screening method using a novel B/02 vs. A/02 discriminating nucleotide substitution at the ABO locus
4. Rh E/e genotyping by allele-specific primer amplification
5. Mutations in the erythrocyte chemokine receptor (Duffy) gene: The molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype
6. Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers
7. ABO glycosyltransferase genotyping by polymerase chain reaction using sequence-specific primers
8. RHD/CE typing by polymerase chain reaction using sequence-specific primers
9. The molecular basis of the Kidd blood group polymorphism and its lack of association with type 1 diabetes susceptibility
10. DNA typing of patients with potentially modified patterns in peripheral blood
11. Blood group genotyping of blood samples from transfused patients
12. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients
13. A recombination hot spot in the Rh genes revealed by analysis of unrelated donors with the rare D--phenotype
14. Molecular basis of the Kell (K1) phenotype
15. Molecular basis for the high-incidence antigens of the Kell blood group system
16. Urea transport and Kidd blood groups
17. Characterization of the gene encoding the human Kidd blood group/urea transporter protein. Evidence for splice site mutations in Jknull individuals
18. Molecular basis and PCR-DNA typing of the Fya/Fyb blood group polymorphism
19. b alloantigen system is associated with a polymorphism at the 44-amino acid residue
20. DUFFY Fy(X) is associated with two missense point mutations in its gene and can be detected by PCR-SSP
21. The human growth hormone locus: Nucleotide sequence, biology, and evolution
22. DNA typing and blood transfusion
23. DNA typing of recipient blood after massive transfusion
24. Leukocyte antigens in renal transplantation. IV. The effect of blood transfusions on leukocyte typing by lymphocytotoxicity
25. Hematopoiesis
26. The effects of blood transfusions on PCR DNA typing at the CSF1P0, TP0X, TH01, D1S80, HLA-DQA1, LDLR, GYPA, HBGG, D7S8 and GC loci
27. Long-term detection of microchimaerism in peripheral blood after pretransplantation blood transfusion
28. Detection of microchimerism after allogeneic blood transfusion using nested polymerase chain reaction amplification with sequence-specific primers (PCR-SSP): A cautionary tale
29. The sensitivity of allele-specific polymerase chain reaction can obviate concern of maternal contamination when fetal samples are genotyped for immune cytopenic disorders
30. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation
31. Presence of donor leukocytes following transfusion in neonates